Systematic Review of Untreated Remission from Alcohol Problems: Estimation Lies in the Eye of the Beholder Richard Mellor1, Kari Lancaster2, Alison Ritter3.

Slides:



Advertisements
Similar presentations
Impact of an antidepressant adherence program in a managed care organization Kara Zivin Bambauer, PhD Stephen Soumerai, ScD Alyce Adams, PhD Fang Zhang,
Advertisements

1 Difference in Difference Models Bill Evans Spring 2008.
Making difficult decisions - Obesity Treatment Eddie Coyle Jane Bray Sara Davies David Cline Jennifer Armstrong Heather Knox.
Models of Evaluation of Addiction Treatment Outcome Post-Treatment vs. During Treatment Evaluation of Effectiveness.
The development of an Australian drug policy index Assoc Prof Alison Ritter Director, Drug Policy Modelling Program (DPMP) University of New South Wales.
Kidane Asmerom and Teh wei-Hu
1 Difference in Difference Models Bill Evans Spring 2008.
Trends in Detection Rates of Risky Marijuana Use in CO Healthcare Settings.
The cost of removing financial barriers to treatment uptake and adherence as effective public health strategies for improving health and reducing HIV transmission.
The Health Development Agency’s approach to evidence Professor Mike Kelly.
1 Is Managed Care Superior to Traditional Fee-For-Service among HIV-Infected Beneficiaries of Medicaid? David Zingmond, MD, PhD UCLA Division of General.
Building pride in Cumbria Do not use fonts other than Arial for your presentations An Overview of Cumbria for Impact Housing Thursday 19 th June 2008 Dr.
Jennifer Hillebrand, „Rehabilitation of Drug Addicted Persons: Experience of Lithuania and European Countries”, 18 October 2007 Improving drug treatment.
Assessment and Treatment of DWI Offenders in Maryland : Current Findings Prepared by: Amelia M. Arria, Ph.D. Center for Substance Abuse Research.
3.5 – Solving Systems of Equations in Three Variables.
Claire Higgins Public Health Development Officer Institute of Public Health in Ireland The Driving Forces for HIA 7 th International.
Gender and Access to Medicines in 15 Low- and Middle-Income Countries: Does Physician Prescribing for Men and Women Differ? Stephens, Peter (1); Ross-Degnan,
The impact of treatment demand data on policy and practice Hamish Sinclair & Jean Long Drug Misuse Research Division Health Research Board Ireland Richard.
Entry and Regulation – Evidence from Health Care Professions Prof. Frank Verboven Presentation at DG-Competition 13 December 2006 “The Economic case for.
Abstinence Incentives for Methadone Maintained Stimulant Users: Outcomes for Those Testing Stimulant Positive vs Negative at Study Intake Maxine L. Stitzer.
Does HIV serosorting increase syphilis prevalence among men who have sex with men in Western Europe? - A mathematical modelling study.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
Estimated Reductions in Influenza-related Mortality among the Elderly through Direct-to-Consumer Advertising of Influenza Vaccine Mitesh S Patel* Matthew.
#LJWG2015 HEPATITIS C IN PEOPLE WHO USE DRUGS Improving Care for Hepatitis C: A Framework Approach LONDON 2015.
ANNUAL COLLOQUIUM 2011 The Expanding House: Extensions to Domestic Buildings and their Impact on Energy Consumption Richard Jack Supervisors: Prof Kevin.
Changing Skill Mix Is it the answer? Professor Bonnie Sibbald National Primary Care Research & Development Centre University of Manchester, England.
Sukanta Saha David Chant Joy Welham John McGrath A systematic review of the prevalence of schizophrenia.
Chapter 9 The Cost of Capital. Copyright ©2014 Pearson Education, Inc. All rights reserved.9-1 Learning Objectives 1.Understand the concepts underlying.
The Health Promotion Package on Alcohol in Denmark Senior Adviser Kit Broholm Copenhagen. ASA EG meeting.
How big is the problem locally? Dr Stephen Willott GP and Clinical Lead for Drug Misuse & Alcohol NHS Nottingham City …& what are we doing about it?
South West Public Health Observatory SOUTH WEST PUBLIC HEALTH SCIENTIFIC CONFERENCE2011 Alcohol Attributable Hospital Admissions in the South West Laura.
Effects of Alcohol on U.S. Adolescent Sleep Patterns: A Systematic Review Nancy Carballo, MSIV Shahrzad Bazargan-Hejazi, PhD 2015 DIDARP 10 th Annual Drug.
Mental Health and Substance Abuse Prescription Drug Spending Trends: Medicaid and Privately Insured Populations American Public Health Association Annual.
Department of Human Services Evaluating Effectiveness of Participation Projects Learning Session Why evaluate the effectiveness of consumer, care and community.
Inference for Population Proportions.   Inference means what you make out of data  Statistics is the practice of measuring Data  Significance! The.
Developing valuable and relevant skills and attributes at L4 to improve retention- a multi-school investigation Alison Day, Dr. Iulia Mihai , Dr. Allan.
International perspectives on drug treatment policy
Prof. R. Michelfelder, Ph.D. Fall 2016 Outline 1
South Yorkshire and Bassetlaw Sustainability and Transformation Plan
Community Councils Discussion Forum 21st April 2012 Delivery of Glasgow City ‘Alcohol & Drug Partnership’ Strategy Stevie Lydon.
Chapter 9 The Cost of Capital.
How Patients Discuss Their Risk: Words and Numbers
Evaluation of 15 projects – ‘Supporting School Leavers’
3.2 Productivity Understand what is meant by productivity.
Direct Variation.
Global epidemiology of injecting drug use
Bruce A. Lawrence, Ted R. Miller, Harold B. Weiss
Alison Ritter, Jenny Chalmers, Lynda Berends
The MDRD Study.
Evaluating Danish Cannabis Policy Change
Freya Vander Laenen STRUCTURED SESSION Costs of drug treatment
Equality Impact Assessing the South Wales Programme
Equation Review Given in class 10/4/13.
Communication Tools: Sample PowerPoint presentation
Jim Orford, on behalf of AFINet project participants
Entry and Regulation – Evidence from Health Care Professions
Registration of treatment demands for substance use disorders in Belgium : Why are some clients registered anonymously? Jérôme Antoine, Françoise Renard.
Health Strategies Group
Tuberculosis in Wales Annual Report 2018 Data to the end of 2017
Untreated Remission from Alcohol Problems: A Mixed Methods Approach
Alcohol, Other Drugs, and Health: Current Evidence
Psychological Measurement: Reliability and the Properties of Random Errors The last two lectures were concerned with some basics of psychological measurement:
Figure 3 Clinical outcome of apheresis therapies for NMOSD attacks
Equation Review.
A system dynamics model of Australian opioid pharmacotherapy maintenance treatment Jenny Chalmers*, Alison Ritter*, Mark Heffernan** and Geoff McDonnell***
Communication Tools: Sample PowerPoint presentation
Number of patients treated at clinics that followed up fewer than 10 patients (2013–2016) or 20 patients (2012) and proportion of patients followed up.
Relations and Functions, Domain & Range
Director of Public Health Report
Tuberculosis in Wales Annual Report 2017 Data to the end of 2016
Presentation transcript:

Systematic Review of Untreated Remission from Alcohol Problems: Estimation Lies in the Eye of the Beholder Richard Mellor1, Kari Lancaster2, Alison Ritter3 1 Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of New South Wales, Sydney; 2 Centre for Social Research in Health, University of New South Wales, Sydney; 3 Drug Policy Modelling Program, Social Policy Research Centre, University of New South Wales, Sydney

Background Treatment Planners need to know how many people with alcohol problems need treatment. This involves estimating the numbers of people who remit without treatment. Estimates of untreated remission from alcohol problems are wide ranging. Systematic review: Examine the ways estimates of untreated remission from alcohol problems are impacted by different methods and definitions. Understand the implications for treatment planning.

Results 124 estimates (across 27 studies): ranged from 2.7% to 98.3%. Methods to Estimation: Method 1: people with alcohol problems; proportion that remit without treatment (mean = 22%). Method 2: untreated people with alcohol problems; proportion that remit (mean = 41%). Method 3: people in remission; proportion that have not received treatment (mean = 43%). Definitional Variability: Alcohol Problem: more lenient definitions - higher estimates (method 2 and 3). Remission: more lenient definitions - higher estimates (all methods). Treatment: more inclusive definitions - lower estimates (method 1 and 3).

Implications for Treatment Planning Treatment resources are limited (do not want to overestimate treated demand). Take people who remit without treatment out of the planning equation. Which estimates treatment planners use will depend upon the goals of the treatment plan.